EXELIXIS, INC. — Director's Dealing 2021

Feb 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2021-02-17

Reporting Person: Schwab Gisela (Pres, Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-17	Common Stock	M	50000	$1.70	Acquired	590597	Direct
2021-02-17	Common Stock	S	50000	$22.50	Disposed	540597	Direct
2021-02-18	Common Stock	M	50000	$1.70	Acquired	590597	Direct
2021-02-18	Common Stock	S	50000	$22.35	Disposed	540597	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-17	Option (right to buy)	$1.7	M	50000	Disposed	2021-09-18	Common Stock (50000.0)	Direct
2021-02-18	Option (right to buy)	$1.7	M	50000	Disposed	2021-09-18	Common Stock (50000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14880	Indirect

Footnotes

F1: Includes 171,083 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 17, 2021.

F3: The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016.